The use of antenatal corticosteroids for fetal maturation: clinical practice guideline by the WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine Foundation
Author(s) -
Themistoklis Dagklis,
Cihat Şen,
Ιoannis Tsakiridis,
Cecilia Villalaín,
Karel Allegaert,
Sven Wellmann,
Satoshi Kusuda,
Bernat Serra,
Manuel Sánchez Luna,
Erasmo Huertas,
N. Volpe,
Rodrigo Ayala,
Nelly Jekova,
Amos Grünebaum,
Milan Stanojević
Publication year - 2022
Publication title -
perinatal journal
Language(s) - English
Resource type - Journals
ISSN - 1305-3124
DOI - 10.2399/prn.22.0301004
Subject(s) - guideline , medicine , perinatal medicine , foundation (evidence) , clinical practice , alternative medicine , family medicine , pediatrics , health care , intensive care medicine , pregnancy , pathology , law , biology , political science , genetics
This practice guideline follows the mission of the World Association of Perinatal Medicine (WAPM) in collaboration with the Perinatal Medicine Foundation (PMF), bringing together groups and individuals throughout the world with the goal of improving the use of antenatal corticosteroids (ACS) for fetal maturation. In fact, this document provides further guidance for healthcare practitioners on the appropriate use of ACS with the aim to increase the timely administration and avoid unnecessary or excessive use. Therefore, it is not intended to establish a legal standard of care. This document is based on consensus among perinatal experts throughout the world and also serves as a guideline for use in clinical practice.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom